Counterpoint: LHRH Agonists vs Ovarian Ablation for Suppression of Ovarian Function in Premenopausal Breast Cancer Patients. Ovarian Ablation Is a Viable Option for Select Patients

Oncology (Williston Park). 2018 Apr 15;32(4):168, 171, 179.

Authors

Philip D Poorvu, Ann H Partridge

PMID: 29684229

No abstract available

MeSH terms

Breast Neoplasms / physiopathology*
Female
Gonadotropin-Releasing Hormone / agonists*
Humans
Ovariectomy*
Ovary / drug effects
Ovary / physiopathology*

Substances

Gonadotropin-Releasing Hormone